Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Affective Disorders

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jad.2016.04.047PMID 27148902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances

  2016cited by this paper
• Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial

  2015cited by this paper
• Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.

  2015cited by this paper
• The use of statins for the treatment of depression in patients with acute coronary syndrome

  2015cited by this paper
• Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study

  2015cited by this paper
• C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

  2015cited by this paper
• Aspirin and statin use and the subsequent development of depression in men and women: Results from a longitudinal population-based study.

  2015cited by this paper
• Early physiological markers of cardiovascular risk in community based adolescents with a depressive disorder.

  2015cited by this paper
• Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

  2015cited by this paper
• Three paths to drug discovery in psychiatry.

  2015cited by this paper
• Statins use and risk of depression: a systematic review and meta-analysis.

  2014cited by this paper
• Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study.

  2014cited by this paper
• Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis

  2014cited by this paper
• Statin use and risk of depression: a Swedish national cohort study

  2014cited by this paper
• Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System

  2014cited by this paper
• In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder.

  2014cited by this paper
• GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.

  2013cited by this paper
• The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study.

  2013cited by this paper
• Clinical depression, antidepressant use and risk of future cardiovascular disease

  2013cited by this paper
• AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE‐BLIND PLACEBO CONTROLLED‐CLINICAL TRIAL

  2013cited by this paper
• The relationship between statins and depression: a review of the literature

  2013cited by this paper
• The role of depression in the primary prevention of cardiovascular disease

  2012cited by this paper
• Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats.

  2012cited by this paper
• Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?

  2012cited by this paper
• The impact of statins on psychological wellbeing: a systematic review and meta-analysis

  2012cited by this paper
• Are depressive symptoms associated with cardiovascular mortality among older Chinese: a cohort study of 64,000 people in Hong Kong?

  2012cited by this paper
• Depression: a global public health concern

  2012cited by this paper
• Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics

  2011cited by this paper
• The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?

  2011cited by this paper
• ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• Association between Depressive Symptoms and Use of HMG-CoA Reductase Inhibitors (Statins), Corticosteroids and Histamine H2 Receptor Antagonists in Community-Dwelling Older Persons

  2008cited by this paper
• Simvastatin Causes Changes in Affective Processes in Elderly Volunteers

  2006cited by this paper
• Statins: much more than just a lipid-lowering therapy.

  2004cited by this paper
• The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes.

  2004cited by this paper
• Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial.

  2003cited by this paper
• Lipid-lowering drugs and the risk of depression and suicidal behavior.

  2003cited by this paper
• Long-term statin use and psychological well-being.

  2003cited by this paper
• Assessing Publication Bias in Meta-Analysis

  2003cited by this paper
• Behavioral implications of lowering cholesterol levels: a double-blind pilot study.

  2003cited by this paper
• Health-Related Quality of Life and Long-Term Therapy with Pravastatin and Tocopherol (Vitamin E) in Older Adults

  2002cited by this paper
• Effects of lovastatin on cognitive function and psychological well-being.

  2000cited by this paper
• Long-term Assessment of Psychological Well-being in a Randomized Placebo-Controlled Trial of Cholesterol Reduction With Pravastatin

  2000cited by this paper
• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

  2000cited by this paper
• Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators.

  2000cited by this paper
• Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

  1998cited by this paper
• Effect of Pharmacologic Lipid Lowering on Health‐Related Quality of Life in Older Persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Commentary: Having too much evidence (depression, suicide, and low serum cholesterol)

  1996cited by this paper
• Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.

  1994cited by this paper
• [A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia].

  1994cited by this paper
• Comparison of Fluvastatin and Lovastatin Blood-Brain Barrier Transfer Using In Vitro and In Vivo Methods

  1993cited by this paper
• Improvement in symptoms of depression and in an index of life stressors accompany treatment of severe hypertriglyceridemia.

  1993cited by this paper

• The association of statin use with the risk of anxiety: a systematic review and meta-analysis.

  2026cites this paper
• Multidisciplinary Management of Depression in Patients with Chronic Illness: Integrating Psychological, Nutritional, Nursing, and Digital Health Approaches

  2025cites this paper
• Związki między stosowaniem statyn a zaburzeniami depresyjnymi oraz zachowaniami samobójczymi

  2025cites this paper
• Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity

  2025cites this paper
• Casein or soy protein supplementation protects against hepatotoxicity in hypercholesterolemic rats treated with rosuvastatin

  2025cites this paper
• Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial

  2024cites this paper
• Lipid parameters and depression in patients with chronic tinnitus: A cross-sectional observation.

  2024cites this paper
• Identifying key biomarkers and therapeutic candidates for post-COVID-19 depression through integrated omics and bioinformatics approaches

  2024cites this paper
• Bidirectional Mendelian randomization analysis of plasma lipidome and psychiatric disorders.

  2024cites this paper
• Pitavastatin attenuates hypercholesterolemia-induced decline in serotonin transporter availability

  2024cites this paper
• "Inflamed" depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression.

  2024cites this paper
• Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression

  2023cites this paper
• Statin for mood and inflammation among adult patients with major depressive disorder: an updated meta-analysis

  2023cites this paper
• Major depressive disorder as a neuro-immune disorder: origin, mechanisms, and therapeutic opportunities.

  2023cites this paper
• Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

  2023cites this paper
• Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions

  2023cites this paper
• Potential strategies to optimize the efficacy of antidepressants: Beyond the monoamine theory

  2023cites this paper
• Associations between individual depressive symptoms and immunometabolic characteristics in major depression.

  2023cites this paper
• Systematic review and meta-analysis of retinal microvascular caliber in bipolar disorder, major depressive disorder, and schizophrenia.

  2023cites this paper
• Pleotropic effects of statins: the dilemma of wider utilization of statin

  2023cites this paper
• Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability

  2022cites this paper
• The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022

  2022cites this paper
• Bioimpedance Body Measures and Serum Lipid Levels in Masculine Depression

  2022cites this paper
• Mutation Burden Analysis of Six Common Mental Disorders in African Americans by Whole Genome Sequencing.

  2022cites this paper
• [The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy].

  2022cites this paper
• The effects of statin monotherapy on depressive symptoms: A systematic review and meta-analysis.

  2022cites this paper
• Association of Depression With 10-Year and Lifetime Cardiovascular Disease Risk Among US Adults, National Health and Nutrition Examination Survey, 2005–2018

  2022cites this paper
• Using Genomic data to Investigate the Anti-Depressive Effects of Statins

  2022influential citation
• The preventive effect of the combination of atorvastatin and nortriptyline in migraine-type headache: a randomized, triple-blind, placebo-controlled trial

  2022cites this paper
• Effect of Low-Dose Statins in Addition to Standard Therapy on Brain Perfusion and Neurocognitive Performance in Patients with Major Depressive Disorder

  2022cites this paper
• Atorvastatin ameliorates depressive behaviors via regulation of α7nAChR expression by PI3K/Akt-BDNF pathway in mice.

  2022cites this paper
• Shared genetic liability between major depressive disorder and osteoarthritis

  2022cites this paper
• Application of deep learning algorithm on whole genome sequencing data uncovers structural variants associated with multiple mental disorders in African American patients

  2022cites this paper
• Bipolar disorder and cardiovascular dysfunction: Mechanisms and implications

  2021cites this paper
• Update on Statin Treatment in Patients with Neuropsychiatric Disorders

  2021cites this paper
• The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study

  2021influential citation
• A chicken and egg scenario in psychoneuroimmunology: Bidirectional mechanisms linking cytokines and depression

  2021cites this paper
• Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder

  2021cites this paper
• An overview on the biological activity and anti-cancer mechanism of lovastatin.

  2021cites this paper
• Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies

  2021cites this paper
• Statins: Neurobiological underpinnings and mechanisms in mood disorders.

  2021cites this paper
• Effects of various statins on depressive symptoms: A network meta-analysis.

  2021cites this paper
• Elevated lipids are associated with reduced regional brain structure in youth with bipolar disorder

  2021cites this paper
• Identification of Statin’s Action in a Small Cohort of Patients with Major Depression

  2021cites this paper
• The pattern of inflammatory markers during electroconvulsive therapy in older depressed patients

  2021cites this paper
• Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials

  2021cites this paper
• Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment

  2021cites this paper
• Physical comorbidities in private psychiatric inpatients: Prevalence and its association with quality of life and functional impairment.

  2020cites this paper
• Clinically relevant drug interactions between statins and antidepressants

  2020cites this paper
• Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin

  2020cites this paper
• Carotid Intima-Media Thickness and Circulation Markers of Inflammation in Patients With Depression

  2020cites this paper
• What is the potential of statins in the treatment of depression?

  2020cites this paper
• Causal relationships between blood lipids and depression phenotypes: a Mendelian randomisation analysis

  2020cites this paper
• Call to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders

  2020cites this paper
• Physical Activity and Body Composition Are Associated With Severity and Risk of Depression, and Serum Lipids

  2020cites this paper
• Statins in the treatment of depression: Hype or hope?

  2020cites this paper
• Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy

  2020cites this paper
• Comorbid depression in medical diseases

  2020cites this paper
• Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study

  2020cites this paper
• The bi-factor structure of the 17-item Hamilton Depression Rating Scale in persistent major depression; dimensional measurement of outcome

  2020cites this paper
• Involvement of Agmatine in Antidepressant-like Effect of HMG- CoA Reductase Inhibitors in Mice.

  2020cites this paper
• Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial

  2020cites this paper
• Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease.

  2020cites this paper
• Correlation between Levels of Serum Cholesterol and Depression in Parasuicide Patients

  2020cites this paper
• LDL cholesterol relates to depression, its severity, and the prospective course

  2019cites this paper
• Statins and Inflammation: New Therapeutic Opportunities in Psychiatry

  2019cites this paper
• Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial

  2019cites this paper
• Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

  2019cites this paper
• Antidepressiva

  2019cites this paper
• TCRM_A_204860 803..810

  2019cites this paper
• Statins: Complex outcomes but increasingly helpful treatment options for patients.

  2019cites this paper
• Beyond evidence‐based treatment of bipolar disorder: Rational pragmatic approaches to management

  2019cites this paper
• Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

  2019cites this paper
• Do statins have an effect on depressive symptoms? A systematic review and meta-analysis.

  2019cites this paper
• Anti-Inflammatory Treatments for Major Depressive Disorder: What's on the Horizon?

  2019cites this paper
• Unraveling the complex interplay of immunometabolic systems that contribute to the neuroprogression of psychiatric disorders

  2019cites this paper
• Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study

  2019cites this paper
• Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions

  2019cites this paper
• Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice

  2019cites this paper
• The association between statin use and depressive symptoms in a large community-dwelling older population: A cross-sectional study.

  2019cites this paper
• Lovastatin Prevents Depressive Behaviors and Increased Hippocampal Neurogenesis in Streptozotocin-Induced Diabetic Mice

  2019cites this paper
• The effect of atorvastatin on cognition and mood in bipolar disorder and unipolar depression patients: A secondary analysis of a randomized controlled trial.

  2019cites this paper
• Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials

  2019cites this paper
• Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice.

  2019cites this paper
• Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale

  2018cites this paper
• Causal relationships between blood lipids and depression phenotypes: A Mendelian randomization analysis

  2018cites this paper
• Risk factors influencing long-term survival and nursing home placement in stroke survivors and patients with carotid stenosis

  2018cites this paper
• Red yeast rice as an adjunct to sertraline for treatment of depression in patients with percutaneous coronary intervention: Placebo-controlled trial

  2018cites this paper
• Some causes of poor adherence to long-term statin therapy and their solution.

  2018cites this paper
• Statin treatment and the risk of depression

  2018cites this paper
• Translating GWAS findings into therapies for depression and anxiety disorders: gene-set analyses reveal enrichment of psychiatric drug classes and implications for drug repositioning

  2018cites this paper
• Statin Use and Cancer Incidence in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis

  2018cites this paper
• Statins and cognition in late‐life bipolar disorder

  2018cites this paper
• Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study

  2018cites this paper
• Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials

  2018cites this paper
• Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome.

  2018cites this paper
• Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets.

  2018cites this paper
• Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years

  2018cites this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

  2018cites this paper
• Anti-inflammatory treatment and risk of depression in 91,842 patients with acute coronary syndrome and 91,860 individuals without acute coronary syndrome in Denmark.

  2017cites this paper